2001 – 2005 Press Releases  
     
 
04/06/05 Plexxikon Signs Broad Kinase Screening Collaboration with Invitrogen
12/09/04 Plexxikon and Phenomix to Develop Drug Candidate for Inflammation
10/28/04 Plexxikon and Wyeth Collaborate to Develop Novel Treatments for Diabetes and Metabolic Disorders
05/26/04 Plexxikon Appoints Dr. C. Ronald Kahn of Joslin Diabetes Center to Scientific Advisory Board;  Raises $15 Million and Adds New Investors Yamanouchi Ventures and NIF Ventures
11/20/03 Plexxikon and Phenomix Announce Drug Discovery Collaboration for Oncology and Inflammation Target
11/13/03 Plexxikon Highlights Research Findings Key to Drug Discovery
for Phosphodiesterase Targets
11/11/03 Plexxikon Achieves Milestone Payment for Lead Compound Selected by Genentech In Drug Discovery Collaboration
05/20/03 Plexxikon and Genentech Announce Drug Discovery Collaboration for Cancer Target
01/15/03 Plexxikon's Scaffold-Based Drug DiscoveryT Platform To Integrate Synthematix' ARTHURT Technology
06/10/02 Plexxikon Chooses Sun Microsystems and Sun Grid Technology to Power Innovative Drug Discovery Platform
04/16/02 Plexxikon Raises $27 Million
04/09/02 Plexxikon Appoints John Kuriyan to Scientific Advisory Board
12/04/01 Plexxikon Signs Agreement with Scynexis to Accelerate Chemistry Efforts
10/31/01 Plexxikon Announces Key Additions to Executive Management Team

2009 | 2008 | 2007 | 2006

Back to Top
  
     
 
Metabolic Disease | Oncology | Inflammation | CNS | Cardio-Renal | Partners
Home | About Plexxikon | Investors | News | Clinical Trials | Careers | Contact Us | Site Map
© 2007 Plexxikon Inc. | Site design by Heiney & Craig